Tech Company Financing Transactions
Evasc Neurovascular Funding Round
Evasc Neurovascular closed a $10 million Series A funding round on 6/16/2017. Investors included Yonghua Capital and private investors.
Transaction Overview
Company Name
Announced On
6/16/2017
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Yonghua Capital (Lead Investor)
Proceeds Purpose
The new funds will be used towards achieving strategic milestones related to the eCLIPs Aneurysm Treatment System in three key areas: Expand use cases--to demonstrate efficacy for: Flow disruption at bifurcations, to eliminate the need for embolization coils. Sidewall aneurysms, to broaden eCLIPs' use to 95% of cerebral aneurysms.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1099 West 8th Ave. 107
Vancouver BC, V6H 1C3
Canada
Vancouver BC, V6H 1C3
Canada
Phone
Website
Email Address
Not Recorded
Overview
Evasc Neurovascular is a privately held medical device company focused on the development of disruptive endovascular treatments for cerebral aneurysms. Evasc received approval for use of eCLIPs in Canada under the Special Access Program in 2013, and received CE mark approval in 2015. Evasc is headquartered in Vancouver, Canada.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Ricci
Chief Financial Officer
Scott Wilson
VP - Engineering
Martina Wan
VP - Sales
Wieger Kaptein
Browse more venture capital transactions:
Prev: 6/16/2017: Entelo venture capital transaction
Next: 6/16/2017: Rythm venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs